Baumgartner H, De Backer J, Babu-Narayan SV et al (2021) 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 42:563–645
Bouchardy J, Therrien J, Pilote L et al (2009) Atrial arrhythmias in adults with congenital heart disease. Circulation 120:1679–1686
Di Mambro C, Yammine ML, Tamborrino PP et al (2024) Long-term incidence of arrhythmias in extracardiac conduit Fontan and comparison between systemic left and right ventricle. Europace 26:euae097. https://doi.org/10.1093/europace/euae097
Article PubMed PubMed Central Google Scholar
Engelings CC, Helm PC, Abdul-Khaliq H et al (2016) Cause of death in adults with congenital heart disease—An analysis of the German National Register for Congenital Heart Defects. Int J Cardiol 211:31–36
Griffiths JR, Nussinovitch U, Liang JJ et al (2022) Catheter Ablation for Atrial Fibrillation in Adult Congenital Heart Disease: An International Multicenter Registry Study. Circ Arrhythm Electrophysiol 15:e10954
Hayes CJ, Gersony WM (1986) Arrhythmias After the Mustard Operation for Transposition of the Great Arteries: A Long-Term Study. J Am Coll Cardiol 7:133–137
Hernandez-Madrid A, Paul T, Abrams D et al (2018) Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace 20:1719–1753
Hessling G (2016) Herzrhythmusstörungen bei Erwachsenen mit angeborenen Herzfehlern: Akut- und Langzeitmanagement. Herzschrittmacherther Elektrophysiol 27:81–87
Kaemmerer H, Bauer U, Pensl U et al (2008) Management of emergencies in adults with congenital cardiac disease. Am J Cardiol 101:521–525
Kawada S, Chakraborty P, Roche L et al (2021) Role of amiodarone in the management of atrial arrhythmias in adult Fontan patients. Heart 107:1062–1068
Khairy P (2022) Primary Prevention Implantable Cardioverter-Defibrillators in Adults With Congenital Heart Disease: Recommendations From Professional Societies. Can J Cardiol 38:536–539
Khairy P, Harris L, Landzberg MJ et al (2008) Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol 1:250–257
Klehs S, Schneider HE, Backhoff D et al (2017) Radiofrequency Catheter Ablation of Atrial Tachycardias in Congenital Heart Disease: Results With Special Reference to Complexity of Underlying Anatomy. Circ Arrhythm Electrophysiol 10:e005451
Koyak Z, Kroon B, De Groot JR et al (2013) Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias. Am J Cardiol 112:1461–1467
Labombarda F, Hamilton R, Shohoudi A et al (2017) Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease. J Am Coll Cardiol 70:857–865
Laubham M, Blais B, Kamp AN (2023) Atrial Arrhythmias in Adults with Fontan Palliation. Cardiol Ther 12:473–487
Article PubMed PubMed Central Google Scholar
Moore BM, Cordina RL, Mcguire MA et al (2019) Efficacy and adverse effects of sotalol in adults with congenital heart disease. Int J Cardiol 274:74–79
Oliver JM, Gallego P, Gonzalez AE et al (2017) Impact of age and sex on survival and causes of death in adults with congenital heart disease. Int J Cardiol 245:119–124
Paul T, Krause U, Sanatani S et al (2023) Advancing the science of management of arrhythmic disease in children and adult congenital heart disease patients within the last 25 years. Europace 25:1–9
Roca-Luque I, Rivas-Gandara N, Dos Subira L et al (2018) Long-Term Follow-Up After Ablation of Intra-Atrial Re-Entrant Tachycardia in Patients With Congenital Heart Disease: Types and Predictors of Recurrence. JACC Clin Electrophysiol 4:771–780
Van Den Bosch AE, Roos-Hesselink JW, Van Domburg R et al (2004) Long-term outcome and quality of life in adult patients after the Fontan operation. Am J Cardiol 93:1141–1145
Vehmeijer JT, Koyak Z, Leerink JM et al (2021) Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD). Heart Rhythm 18:785–792
Walsh EP (2007) Interventional electrophysiology in patients with congenital heart disease. Circulation 115:3224–3234
Warnes CA (2006) Transposition of the great arteries. Circulation 114:2699–2709
Yang H, Bouma BJ, Dimopoulos K et al (2020) Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study. Int J Cardiol 299:123–130
Yang H, Kuijpers JM, De Groot JR et al (2017) Impact of atrial arrhythmias on outcome in adults with congenital heart disease. Int J Cardiol 248:152–154
留言 (0)